Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Kaituhi rangatōpū: | |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
New York :
Nova Biomedical Books,
c2010.
|
| Rangatū: | Metabolic diseases--laboratory and clinical research series.
Novinka (Series) |
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- NAFLD and insulin resistance (IR)
- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines
- Adiponectin and NASH
- TNF-[alpha] and NAFLD/NASH
- Leptin and NAFLD/NASH
- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH
- Iron overload and NAFLD/NASH
- Mitochondrial abnormalities and NAFLD/NASH
- Genetic influences in NAFLD/NASH
- Therapeutic strategy for NASH patients
- Natural history of NAFLD
- Conclusions.